APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pegcetacoplan Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pegcetacoplan Injection Industry Growth and Trends Forecast to 2032

28 December 202578 pages

Choose your research edition.

Industry ResearchPegcetacoplan Injection Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Pegcetacoplan Injection Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Pegcetacoplan Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pegcetacoplan Injection Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pegcetacoplan Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Pegcetacoplan Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pegcetacoplan Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pegcetacoplan Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pegcetacoplan Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pegcetacoplan Injection include Apellis Pharmaceuticals. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pegcetacoplan Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pegcetacoplan Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pegcetacoplan Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pegcetacoplan Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pegcetacoplan Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pegcetacoplan Injection Market by Company

Apellis Pharmaceuticals

Pegcetacoplan Injection Segment by Type

Subcutaneous Injection

Intravitreal Injection

Pegcetacoplan Injection Segment by Application

Retinal Geographic Atrophy

Paroxysmal Nocturnal Hemoglobinuria

Others

Pegcetacoplan Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pegcetacoplan Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pegcetacoplan Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pegcetacoplan Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pegcetacoplan Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pegcetacoplan Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Subcutaneous Injection Table 2. Major Company of Intravitreal Injection Table 3. Global Pegcetacoplan Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Pegcetacoplan Injection Sales by Type (2021-2026) & (K Units) Table 5. Global Pegcetacoplan Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Pegcetacoplan Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Pegcetacoplan Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Pegcetacoplan Injection Price by Type (2021-2026) & (US$/Unit) Table 9. Global Pegcetacoplan Injection Sales by Type (2027-2032) & (K Units) Table 10. Global Pegcetacoplan Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Pegcetacoplan Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Pegcetacoplan Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Pegcetacoplan Injection Price by Type (2027-2032) & (US$/Unit) Table 14. North America Pegcetacoplan Injection Sales by Type (2021-2026) & (K Units) Table 15. North America Pegcetacoplan Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Pegcetacoplan Injection Sales by Type (2021-2026) & (K Units) Table 17. Europe Pegcetacoplan Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Pegcetacoplan Injection Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Pegcetacoplan Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Pegcetacoplan Injection Sales by Type (2021-2026) & (K Units) Table 21. Latin America Pegcetacoplan Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Pegcetacoplan Injection Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Pegcetacoplan Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Pegcetacoplan Injection Industry Trends Table 25. Pegcetacoplan Injection Industry Drivers Table 26. Pegcetacoplan Injection Industry Opportunities and Challenges Table 27. Pegcetacoplan Injection Industry Restraints Table 28. Global Pegcetacoplan Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Pegcetacoplan Injection Revenue Market Share by Company (2021-2026) Table 30. Global Pegcetacoplan Injection Sales by Company (2021-2026) & (K Units) Table 31. Global Pegcetacoplan Injection Sales Share by Company (2021-2026) Table 32. Global Pegcetacoplan Injection Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Pegcetacoplan Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Pegcetacoplan Injection Major Company Production Sites and Headquarters Table 35. Global Pegcetacoplan Injection Company, Product Type & Application Table 36. Global Pegcetacoplan Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Pegcetacoplan Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Pegcetacoplan Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Pegcetacoplan Injection Sales by Region (2021-2026) & (K Units) Table 41. Global Pegcetacoplan Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Pegcetacoplan Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Pegcetacoplan Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Pegcetacoplan Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Pegcetacoplan Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Pegcetacoplan Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Pegcetacoplan Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Pegcetacoplan Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Pegcetacoplan Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Pegcetacoplan Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Pegcetacoplan Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Pegcetacoplan Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Pegcetacoplan Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Pegcetacoplan Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Pegcetacoplan Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Pegcetacoplan Injection Sales by Application (2027-2032) & (K Units) Table 57. Global Pegcetacoplan Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Pegcetacoplan Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Pegcetacoplan Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Pegcetacoplan Injection Price by Application (2027-2032) & (US$/Unit) Table 61. North America Pegcetacoplan Injection Sales by Application (2021-2026) & (K Units) Table 62. North America Pegcetacoplan Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Pegcetacoplan Injection Sales by Application (2021-2026) & (K Units) Table 64. Europe Pegcetacoplan Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Pegcetacoplan Injection Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Pegcetacoplan Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Pegcetacoplan Injection Sales by Application (2021-2026) & (K Units) Table 68. Latin America Pegcetacoplan Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Pegcetacoplan Injection Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Pegcetacoplan Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Apellis Pharmaceuticals Company Information Table 72. Apellis Pharmaceuticals Business Overview Table 73. Apellis Pharmaceuticals Pegcetacoplan Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Apellis Pharmaceuticals Pegcetacoplan Injection Product Portfolio Table 75. Apellis Pharmaceuticals Recent Development Table 76. North America Pegcetacoplan Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 77. North America Pegcetacoplan Injection Sales by Country (2021-2026) & (K Units) Table 78. North America Pegcetacoplan Injection Sales Market Share by Country (2021-2026) Table 79. North America Pegcetacoplan Injection Sales Forecast by Country (2027-2032) & (K Units) Table 80. North America Pegcetacoplan Injection Sales Market Share Forecast by Country (2027-2032) Table 81. North America Pegcetacoplan Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 82. North America Pegcetacoplan Injection Market Size by Country (2021-2026) & (US$ Million) Table 83. North America Pegcetacoplan Injection Market Share by Country (2021-2026) Table 84. North America Pegcetacoplan Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 85. North America Pegcetacoplan Injection Market Share Forecast by Country (2027-2032) Table 86. Europe Pegcetacoplan Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 87. Europe Pegcetacoplan Injection Sales by Country (2021-2026) & (K Units) Table 88. Europe Pegcetacoplan Injection Sales Market Share by Country (2021-2026) Table 89. Europe Pegcetacoplan Injection Sales Forecast by Country (2027-2032) & (K Units) Table 90. Europe Pegcetacoplan Injection Sales Market Share Forecast by Country (2027-2032) Table 91. Europe Pegcetacoplan Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. Europe Pegcetacoplan Injection Market Size by Country (2021-2026) & (US$ Million) Table 93. Europe Pegcetacoplan Injection Market Share by Country (2021-2026) Table 94. Europe Pegcetacoplan Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. Europe Pegcetacoplan Injection Market Share Forecast by Country (2027-2032) Table 96. Asia-Pacific Pegcetacoplan Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 97. Asia-Pacific Pegcetacoplan Injection Sales by Country (2021-2026) & (K Units) Table 98. Asia-Pacific Pegcetacoplan Injection Sales Market Share by Country (2021-2026) Table 99. Asia-Pacific Pegcetacoplan Injection Sales Forecast by Country (2027-2032) & (K Units) Table 100. Asia-Pacific Pegcetacoplan Injection Sales Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Pegcetacoplan Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Pegcetacoplan Injection Market Size by Country (2021-2026) & (US$ Million) Table 103. Asia-Pacific Pegcetacoplan Injection Market Share by Country (2021-2026) Table 104. Asia-Pacific Pegcetacoplan Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Asia-Pacific Pegcetacoplan Injection Market Share Forecast by Country (2027-2032) Table 106. Latin America Pegcetacoplan Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. Latin America Pegcetacoplan Injection Sales by Country (2021-2026) & (K Units) Table 108. Latin America Pegcetacoplan Injection Sales Market Share by Country (2021-2026) Table 109. Latin America Pegcetacoplan Injection Sales Forecast by Country (2027-2032) & (K Units) Table 110. Latin America Pegcetacoplan Injection Sales Market Share Forecast by Country (2027-2032) Table 111. Latin America Pegcetacoplan Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Latin America Pegcetacoplan Injection Market Size by Country (2021-2026) & (US$ Million) Table 113. Latin America Pegcetacoplan Injection Market Share by Country (2021-2026) Table 114. Latin America Pegcetacoplan Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Latin America Pegcetacoplan Injection Market Share Forecast by Country (2027-2032) Table 116. Middle East and Africa Pegcetacoplan Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Middle East and Africa Pegcetacoplan Injection Sales by Country (2021-2026) & (K Units) Table 118. Middle East and Africa Pegcetacoplan Injection Sales Market Share by Country (2021-2026) Table 119. Middle East and Africa Pegcetacoplan Injection Sales Forecast by Country (2027-2032) & (K Units) Table 120. Middle East and Africa Pegcetacoplan Injection Sales Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Pegcetacoplan Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Pegcetacoplan Injection Market Size by Country (2021-2026) & (US$ Million) Table 123. Middle East and Africa Pegcetacoplan Injection Market Share by Country (2021-2026) Table 124. Middle East and Africa Pegcetacoplan Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Middle East and Africa Pegcetacoplan Injection Market Share Forecast by Country (2027-2032) Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Pegcetacoplan Injection Distributors List Table 129. Pegcetacoplan Injection Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Pegcetacoplan Injection Image Figure 2. Global Pegcetacoplan Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pegcetacoplan Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Pegcetacoplan Injection Sales (2021-2032) & (K Units) Figure 5. Subcutaneous Injection Image Figure 6. Global Subcutaneous Injection Sales YoY Growth (2021-2032) & (K Units) Figure 7. Intravitreal Injection Image Figure 8. Global Intravitreal Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Pegcetacoplan Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Pegcetacoplan Injection Market Share by Type 2025 VS 2032 Figure 11. North America Pegcetacoplan Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Pegcetacoplan Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Pegcetacoplan Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Pegcetacoplan Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Pegcetacoplan Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Pegcetacoplan Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Pegcetacoplan Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Pegcetacoplan Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Pegcetacoplan Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Pegcetacoplan Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Pegcetacoplan Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Retinal Geographic Atrophy Image Figure 24. Global Retinal Geographic Atrophy Sales YoY Growth (2021-2032) & (K Units) Figure 25. Paroxysmal Nocturnal Hemoglobinuria Image Figure 26. Global Paroxysmal Nocturnal Hemoglobinuria Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Pegcetacoplan Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Pegcetacoplan Injection Market Share by Application 2025 VS 2032 Figure 31. North America Pegcetacoplan Injection Sales Market Share in Volume by Application in 2025 Figure 32. North America Pegcetacoplan Injection Sales Market Share in Value by Application in 2025 Figure 33. Europe Pegcetacoplan Injection Sales Market Share in Volume by Application in 2025 Figure 34. Europe Pegcetacoplan Injection Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Pegcetacoplan Injection Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Pegcetacoplan Injection Sales Market Share in Value by Application in 2025 Figure 37. Latin America Pegcetacoplan Injection Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Pegcetacoplan Injection Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Pegcetacoplan Injection Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Pegcetacoplan Injection Sales Market Share in Value by Application in 2025 Figure 41. North America Pegcetacoplan Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Pegcetacoplan Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Pegcetacoplan Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Pegcetacoplan Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Pegcetacoplan Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Pegcetacoplan Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pegcetacoplan Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Pegcetacoplan Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Pegcetacoplan Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Pegcetacoplan Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pegcetacoplan Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Pegcetacoplan Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Pegcetacoplan Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Pegcetacoplan Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pegcetacoplan Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Pegcetacoplan Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Pegcetacoplan Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Pegcetacoplan Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pegcetacoplan Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Pegcetacoplan Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Pegcetacoplan Injection Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Pegcetacoplan Injection Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Subcutaneous Injection
  • Intravitreal Injection
Applications
  • Retinal Geographic Atrophy
  • Paroxysmal Nocturnal Hemoglobinuria
  • Others
Companies covered
  • Apellis Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pegcetacoplan Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pegcetacoplan Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pegcetacoplan Injection Market by Type
  6. 1.3.1 Subcutaneous Injection
  7. 1.3.2 Intravitreal Injection
  8. 1.4 Global Pegcetacoplan Injection Market Size by Type
  9. 1.4.1 Global Pegcetacoplan Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Pegcetacoplan Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Pegcetacoplan Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Pegcetacoplan Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Pegcetacoplan Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Pegcetacoplan Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Pegcetacoplan Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Pegcetacoplan Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pegcetacoplan Injection Industry Trends
  2. 2.2 Pegcetacoplan Injection Industry Drivers
  3. 2.3 Pegcetacoplan Injection Industry Opportunities and Challenges
  4. 2.4 Pegcetacoplan Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pegcetacoplan Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Pegcetacoplan Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Pegcetacoplan Injection Price (2021-2026)
  4. 3.4 Global Pegcetacoplan Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pegcetacoplan Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Pegcetacoplan Injection Company, Product Type & Application
  7. 3.7 Global Pegcetacoplan Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pegcetacoplan Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pegcetacoplan Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pegcetacoplan Injection Tier 1, Tier 2, and Tier 3
4 Pegcetacoplan Injection Regional Status and Outlook
  1. 4.1 Global Pegcetacoplan Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pegcetacoplan Injection Historic Market Size by Region
  3. 4.2.1 Global Pegcetacoplan Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pegcetacoplan Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pegcetacoplan Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pegcetacoplan Injection Forecasted Market Size by Region
  7. 4.3.1 Global Pegcetacoplan Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pegcetacoplan Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pegcetacoplan Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pegcetacoplan Injection by Application
  1. 5.1 Pegcetacoplan Injection Market by Application
  2. 5.1.1 Retinal Geographic Atrophy
  3. 5.1.2 Paroxysmal Nocturnal Hemoglobinuria
  4. 5.1.3 Others
  5. 5.2 Global Pegcetacoplan Injection Market Size by Application
  6. 5.2.1 Global Pegcetacoplan Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Pegcetacoplan Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Pegcetacoplan Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Pegcetacoplan Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Pegcetacoplan Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Pegcetacoplan Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Pegcetacoplan Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Pegcetacoplan Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Apellis Pharmaceuticals
  2. 6.1.1 Apellis Pharmaceuticals Company Information
  3. 6.1.2 Apellis Pharmaceuticals Business Overview
  4. 6.1.3 Apellis Pharmaceuticals Pegcetacoplan Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Apellis Pharmaceuticals Pegcetacoplan Injection Product Portfolio
  6. 6.1.5 Apellis Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Pegcetacoplan Injection Sales by Country
  2. 7.1.1 North America Pegcetacoplan Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pegcetacoplan Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Pegcetacoplan Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pegcetacoplan Injection Market Size by Country
  6. 7.2.1 North America Pegcetacoplan Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pegcetacoplan Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Pegcetacoplan Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pegcetacoplan Injection Sales by Country
  2. 8.1.1 Europe Pegcetacoplan Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pegcetacoplan Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Pegcetacoplan Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pegcetacoplan Injection Market Size by Country
  6. 8.2.1 Europe Pegcetacoplan Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pegcetacoplan Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pegcetacoplan Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pegcetacoplan Injection Sales by Country
  2. 9.1.1 Asia-Pacific Pegcetacoplan Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pegcetacoplan Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pegcetacoplan Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pegcetacoplan Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Pegcetacoplan Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pegcetacoplan Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pegcetacoplan Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pegcetacoplan Injection Sales by Country
  2. 10.1.1 South America Pegcetacoplan Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pegcetacoplan Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Pegcetacoplan Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pegcetacoplan Injection Market Size by Country
  6. 10.2.1 South America Pegcetacoplan Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pegcetacoplan Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Pegcetacoplan Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pegcetacoplan Injection Sales by Country
  2. 11.1.1 Middle East and Africa Pegcetacoplan Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pegcetacoplan Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pegcetacoplan Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pegcetacoplan Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Pegcetacoplan Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pegcetacoplan Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pegcetacoplan Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pegcetacoplan Injection Value Chain Analysis
  2. 12.1.1 Pegcetacoplan Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pegcetacoplan Injection Production Mode & Process
  7. 12.2 Pegcetacoplan Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pegcetacoplan Injection Distributors
  10. 12.2.3 Pegcetacoplan Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst